The RIQAS Therapeutic Drug EQA programme is designed to monitor the performance of an impressive 18 therapeutic drugs. Weighed in values are reported for each parameter.
Lyophilised material for enhanced stability

Submit results and view reports online via Riqas.com
Worlds largest EQA scheme ensuring peer groups are maximised
Bi-Weekly reporting for early identification of test system errors
Cycle Starts - March/September 2026
Accredited to ISO/IEC 17043:2023
To find out more about RIQAS EQA or to get in touch with your local Randox Representative, enquire now.
| Description | Frequency | Size | Cat No | |
|---|---|---|---|---|
| Therapeutic Drugs | Bi-Weekly | 12 x 5 ml | RQ9111 |
General Clinical Chemistry
Immunoassay
Immunoassay Speciality 1